QUOIN PHARMACEUTICALS, INC.

Lobbying client · Virginia · filed 2025 to 2026

Development and commercialization of therapeutic drug products that treat rare diseases.

$100,000 Reported spend

7 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page is grouped by the client's LDA id (66065), not by name.

Firms hired 1

FORWARD GLOBAL $100,000 7 filings

Reported by year 2 years

2026 $40,000 2 filings
2025 $60,000 5 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 5
SENATE 5

Recent filings 7 total

Q2

FORWARD GLOBAL

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $20,000 income · posted Jul 20, 2026

View → Q1

FORWARD GLOBAL

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $20,000 income · posted Apr 20, 2026

View → Q4

FORWARD GLOBAL

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $20,000 income · posted Jan 20, 2026

View → Q3

FORWARD GLOBAL

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $20,000 income · posted Oct 20, 2025

View → Q2

FORWARD GLOBAL

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $20,000 income · posted Jul 21, 2025

View → Q1Y

FORWARD GLOBAL

1st Quarter (Jan 1 - Mar 31) 2025 · posted Apr 21, 2025

View → RR

FORWARD GLOBAL

1st Quarter (Jan 1 - Mar 31) 2025 · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.